Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF).

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Cardiology

• Publication date

  1997-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(97)00396-2PMID 9285659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.

  1997cited by this paper
• Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

  1995cited by this paper
• Tree-structured prediction for censored survival data and the Cox model.

  1995cited by this paper
• Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

  1994cited by this paper
• Managing Chronic Atrial Fibrillation: A Markov Decision Analysis Comparing Warfarin, Quinidine, and Low-Dose Amiodarone

  1994cited by this paper
• The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

  1994cited by this paper
• Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials.

  1993cited by this paper
• Antithrombotic therapy in atrial fibrillation.

  1992cited by this paper
• Low-dose amiodarone for atrial fibrillation: time for a prospective study?

  1992cited by this paper
• Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter.

  1992cited by this paper
• Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study.

  1992cited by this paper
• Evolving strategies for the management of atrial fibrillation. The role of amiodarone.

  1992cited by this paper
• Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.

  1989cited by this paper
• Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias.

  1989cited by this paper
• Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium.

  1987cited by this paper
• Amiodarone in the management of refractory atrial fibrillation.

  1987cited by this paper
• Amiodarone for refractory atrial fibrillation.

  1986cited by this paper
• Comparison of amiodarone and disopyramide in the control of paroxysmal atrial fibrillation and atrial flutter (interim report).

  1986cited by this paper
• Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy.

  1985cited by this paper
• Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.

  1983cited by this paper
• Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.

  1981cited by this paper
• On distribution-free tests for equality of survival distributions

  1977cited by this paper
• A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship

  1970cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper

• Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.

  2023cites this paper
• Management of atrial fibrillation: two decades of progress — a scientific statement from the European Cardiac Arrhythmia Society

  2022cites this paper
• Impact of Catheter Ablation for Atrial Fibrillation on Quality of Life

  2022cites this paper
• Fibrillazione atriale: cardiovertire sempre? Parere contro

  2020cites this paper
• Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis.

  2019cites this paper
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

  2019cites this paper
• CLINICOFUNCTIONAL CHARACTERISTIC OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION AGAINST THE BACKGROUND OF ACUTE ATRIAL FIBRILLATION

  2016cites this paper
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

  2015cites this paper
• The state of patient-reported outcomes in atrial fibrillation

  2012cites this paper
• New Approaches to Atrial Fibrillation Management

  2012cites this paper
• A randomized trial of budiodarone in paroxysmal atrial fibrillation

  2012cites this paper
• Defining endpoints in clinical trials on atrial fibrillation

  2008cites this paper
• Defining endpoints in clinical trials on atrial fibrillation

  2008cites this paper
• Electrical cardioversion for atrial fibrillation and flutter.

  2005cites this paper
• Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research?

  2003cites this paper
• Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.

  2002cites this paper
• Maintaining stability of sinus rhythm in atrial fibrillation: Antiarrhythmic drugs versus ablation

  2002cites this paper
• Electrical cardioversion for atrial fibrillation and flutter.

  2002cites this paper
• Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial.

  2002cites this paper
• Frequency-Dependent Electrophysiological Effect of Ibutilide on Human Atrium and Ventricle

  2001cites this paper
• Overview of Atrial Fibrillation Trials

  2000cites this paper
• Review : Pharmacological Management of Atrial Fibrillation: An Update

  2000cites this paper
• Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

  2000cites this paper
• Amiodarone to Prevent Recurrence of Atrial Fibrillation

  2000cites this paper
• AMIODARONE TO PREVENT RECURRENCE OF ATRIAL FIBRILLATION AMIODARONE TO PREVENT RECURRENCE OF ATRIAL FIBRILLATION

  2000cites this paper
• Therapy of Atrial Fibrillation: Rhythm Control Versus Rate Control

  2000cites this paper
• Pharmacological management of atrial fibrillation: an update.

  2000cites this paper
• Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

  2000cites this paper
• The role of class III antiarrhythmic agents in maintaining sinus rhythm.

  2000cites this paper
• Clinical Implications of the Canadian Trial of Atrial Fibrillation (CTAF)

  2000cites this paper
• Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease.

  1999cites this paper
• The Role of Nonpharmacologic Therapies for the Treatment of Atrial Fibrillation

  1999cites this paper
• Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation

  1999cites this paper
• Aspectos Epidemiológicos, Etiologia e Classificaçao da Fibrilaçao Atrial

  1999cites this paper
• Atrial fibrillation: overview of therapeutic trials.

  1998cites this paper
• Is There a Future for Antiarrhythmic Drug Therapy?

  1998cites this paper
• Atrial fibrillation trials: will they teach us what we need to know?

  1998cites this paper
• Long-Term Pharmacologic Management of Atrial Fibrillation for Control of Rate and Rhythm

  1997cites this paper